In contrast, Kosmider and collegues identified CSF3R mutations in 3% CMML patients and showed that CSF3R mutations were associated with an reduced OS and AML-free survival in univariate analysis [8]. The gene discussed is CSF3R; the disease is acute myeloid leukemia.